Department of Materials Science, Graduate School of Pure and Applied Sciences, University of Tsukuba, Tennoudai 1-1-1, Tsukuba 305-8573, Japan.
J Control Release. 2013 Dec 28;172(3):914-20. doi: 10.1016/j.jconrel.2013.10.009. Epub 2013 Oct 21.
Reactive oxygen species (ROS) scavengers have not been widely used for treatment of local inflammatory reactions such as arthritis and periodontal disease because they are rapidly eliminated from the inflamed site, which results in a low therapeutic effect. Therefore, to enhance the local retention time of ROS scavengers, we developed a redox-active injectable gel (RIG) system by using poly[4-(2,2,6,6-tetramethylpiperidine-N-oxyl)aminomethylstyrene]-b-poly(ethylene glycol)-b-poly[4-(2,2,6,6-tetramethylpiperidine-N-oxyl)aminomethylstyrene] (PMNT-PEG-PMNT) triblock copolymer, which possesses ROS scavenging nitroxide radicals as side chains of the PMNT segment. Cationic PMNT segment in PMNT-PEG-PMNT forms polyion complexes with anionic poly(acrylic acid) (PAAc) to form a flower-like micelle (ca. 79 nm), which exhibits in situ thermo-irreversible gelation under physiological conditions. We confirmed the prolonged site-specific retention time of RIG by performing in vivo noninvasive electron spin resonance imaging and quantitative evaluation. In contrast to low-molecular-weight nitroxide radical compounds that disappeared from injection sites in less than 1h after subcutaneous injection, 40% of the RIG remained even at 3 days. We also found that RIG inhibits neutrophil infiltration and cytokine production, which leads to suppression of hyperalgesia. These findings indicate the potential of RIG as an innovative approach for treatment of local inflammation.
活性氧 (ROS) 清除剂尚未广泛用于治疗关节炎和牙周病等局部炎症反应,因为它们会从炎症部位迅速消除,从而导致治疗效果不佳。因此,为了增强 ROS 清除剂的局部滞留时间,我们开发了一种氧化还原活性可注射凝胶 (RIG) 系统,该系统使用聚[4-(2,2,6,6-四甲基哌啶-N-氧代)氨基甲基苯乙烯]-b-聚(乙二醇)-b-聚[4-(2,2,6,6-四甲基哌啶-N-氧代)氨基甲基苯乙烯] (PMNT-PEG-PMNT) 三嵌段共聚物,该共聚物具有作为 PMNT 段侧链的 ROS 清除氮氧自由基。PMNT-PEG-PMNT 中的阳离子 PMNT 段与阴离子聚丙烯酸 (PAAc) 形成聚离子复合物,形成花状胶束(约 79nm),在生理条件下可原位形成热不可逆凝胶。我们通过进行体内无创电子顺磁共振成像和定量评估证实了 RIG 的延长的局部特异性保留时间。与皮下注射后不到 1 小时就从注射部位消失的低分子量氮氧自由基化合物相比,RIG 有 40%甚至在 3 天后仍存在。我们还发现 RIG 抑制中性粒细胞浸润和细胞因子产生,从而抑制痛觉过敏。这些发现表明 RIG 作为治疗局部炎症的创新方法具有潜力。